Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC Jürgen C. BeckerAndreas StangDavid Schrama Review 30 November 2017 Pages: 341 - 351
Tumor-derived high-mobility group box 1 and thymic stromal lymphopoietin are involved in modulating dendritic cells to activate T regulatory cells in a mouse model Yi ZhangZuqiang LiuZhaoyang You Original Article 07 November 2017 Pages: 353 - 366
Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model Afshin NamdarReza MirzaeiJamshid Hadjati Original Article 09 November 2017 Pages: 367 - 379
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy David BriereNiranjan SudhakarJames G. Christensen Original Article 09 November 2017 Pages: 381 - 392
Targeting and suppression of HER3-positive breast cancer by T lymphocytes expressing a heregulin chimeric antigen receptor Bai-Le ZuoBo YanLin-Tao Jia Original Article 10 November 2017 Pages: 393 - 401
High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients Johannes BreyerRalph M. WirtzArndt Hartmann Original Article 17 November 2017 Pages: 403 - 412
Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737 Theresa NollSusanne Schultze-SeemannPhilipp Wolf Original Article 29 November 2017 Pages: 413 - 422
Therapeutic reduction of cell-mediated immunosuppression in mycosis fungoides and Sézary syndrome Larisa J. GeskinOleg E. AkilovLouis D. Falo Jr. Original Article 04 December 2017 Pages: 423 - 434
The Immunoscore system predicts prognosis after liver metastasectomy in colorectal cancer liver metastases Yun WangHao-cheng LinYu-hong Li Original Article 04 December 2017 Pages: 435 - 444
Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors Kamiya MehlaJarrod TremayneMichael A. Hollingsworth Original Article 04 December 2017 Pages: 445 - 457
Post-treatment neutrophil-to-lymphocyte ratio at week 6 is prognostic in patients with advanced non-small cell lung cancers treated with anti-PD-1 antibody Koung Jin SuhSe Hyun KimJong Seok Lee Original Article 04 December 2017 Pages: 459 - 470
Characterization of PD-L1 expression in Chinese non-small cell lung cancer patients with PTEN expression as a means for tissue quality screening Xu-chao ZhangXu CaoYi-long Wu Original Article 06 December 2017 Pages: 471 - 481
Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells Veronika BachanovaDhifaf SarhanJeffrey S. Miller Original Article 07 December 2017 Pages: 483 - 494
High PD-L1 expression indicates poor prognosis of HIV-infected patients with non-small cell lung cancer Yusuke OkumaTsunekazu HishimaSadamu Homma Original Article 14 December 2017 Pages: 495 - 505